{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:31:25Z","timestamp":1789579885552,"version":"build-2803163510"},"reference-count":19,"publisher":"American Academy of Pediatrics (AAP)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3,1]]},"abstract":"<jats:p>Primary intestinal lymphangiectasia (PIL), also known as Waldmann\u2019s disease, is an exudative enteropathy resulting from morphologic abnormalities in the intestinal lymphatics. In this article, we describe a 12-year-old boy with PIL that led to protein-losing enteropathy characterized by diarrhea, hypoalbuminemia associated with edema (serum albumin level: 1.0 g\/dL), and hypogammaglobulinemia (serum IgG level: 144 mg\/dL). Severe hypoalbuminemia, electrolyte abnormalities, and tetany persisted despite a low-fat diet and propranolol. Everolimus (1.6 mg\/m2\/day) was added to his treatment as an antiangiogenic agent. With everolimus treatment, the patient\u2019s diarrhea resolved and replacement therapy for hypoproteinemia was less frequent. Hematologic and scintigraphy findings also improved (serum albumin level: 2.5 g\/dL). There were no adverse reactions during the 12-month follow-up. To the best of our knowledge, this is the first report of everolimus use in a patient with PIL.<\/jats:p>","DOI":"10.1542\/peds.2015-2562","type":"journal-article","created":{"date-parts":[[2016,2,17]],"date-time":"2016-02-17T02:11:12Z","timestamp":1455675072000},"source":"Crossref","is-referenced-by-count":25,"title":["Everolimus for Primary Intestinal Lymphangiectasia With Protein-Losing Enteropathy"],"prefix":"10.1542","volume":"137","author":[{"given":"Michio","family":"Ozeki","sequence":"first","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Hori","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Kanda","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norio","family":"Kawamoto","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ibuka","sequence":"additional","affiliation":[{"name":"Gastroenterology, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuhiko","family":"Miyazaki","sequence":"additional","affiliation":[{"name":"Pathology, Gifu University Graduate School of Medicine, Gifu University, Gifu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Fukao","sequence":"additional","affiliation":[{"name":"Departments of Pediatrics,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2016,3,1]]},"reference":[{"issue":"4","key":"2021121023274433900_B1","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1053\/j.sempedsurg.2014.07.006","article-title":"Complex lymphatic anomalies.","volume":"23","author":"Trenor","year":"2014","journal-title":"Semin Pediatr Surg"},{"key":"2021121023274433900_B2","unstructured":"International Society for the Study of Vascular Anomalies\n          . ISSVA classification for vascular anomalies. Available at: www.issva.org. Accessed May 2, 2015"},{"issue":"4","key":"2021121023274433900_B3","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00247-014-3191-x","article-title":"Pediatric lymphangiectasia: an imaging spectrum.","volume":"45","author":"Malone","year":"2015","journal-title":"Pediatr Radiol"},{"issue":"5","key":"2021121023274433900_B4","article-title":"Primary intestinal lymphangiectasia (Waldmann\u2019s disease).","volume":"3","author":"Vignes","year":"2008","journal-title":"Orphanet J Rare Dis"},{"key":"2021121023274433900_B5","first-page":"1665","article-title":"Disorders of absorption","volume-title":"Harrison\u2019s principles of internal medicine","author":"Binder","year":"2001","edition":"15th ed."},{"issue":"2","key":"2021121023274433900_B6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s005350170142","article-title":"Primary intestinal lymphangiectasia successfully treated with octreotide.","volume":"36","author":"Kuroiwa","year":"2001","journal-title":"J Gastroenterol"},{"issue":"6","key":"2021121023274433900_B7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/pbc.23124","article-title":"Sirolimus for the treatment of complicated vascular anomalies in children.","volume":"57","author":"Hammill","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"12","key":"2021121023274433900_B8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1007\/s00431-015-2572-y","article-title":"Sirolimus for the treatment of children with various complicated vascular anomalies.","volume":"174","author":"Lackner","year":"2015","journal-title":"Eur J Pediatr"},{"issue":"2","key":"2021121023274433900_B9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/adc.78.2.194","article-title":"Intestinal lymphangiectasia and protein losing enteropathy responding to small bowel restriction [letter].","volume":"78","author":"Persi\u0107","year":"1998","journal-title":"Arch Dis Child"},{"issue":"1","key":"2021121023274433900_B10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1620\/tjem.229.61","article-title":"Propranolol as an alternative treatment option for pediatric lymphatic malformation.","volume":"229","author":"Ozeki","year":"2013","journal-title":"Tohoku J Exp Med"},{"issue":"14","key":"2021121023274433900_B11","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJMc1013217","article-title":"Propranolol for intractable diffuse lymphangiomatosis.","volume":"364","author":"Ozeki","year":"2011","journal-title":"N Engl J Med"},{"issue":"4","key":"2021121023274433900_B12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/annonc\/mdi113","article-title":"mTOR-targeted therapy of cancer with rapamycin derivatives.","volume":"16","author":"Vignot","year":"2005","journal-title":"Ann Oncol"},{"issue":"7 Pt 2","key":"2021121023274433900_B13","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1111\/j.1440-1746.2007.05225.x","article-title":"Changes in regulatory molecules for lymphangiogenesis in intestinal lymphangiectasia with enteric protein loss.","volume":"23","author":"Hokari","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"issue":"7376","key":"2021121023274433900_B14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0140-6736(65)91657-0","article-title":"Intestinal lymphangiectasia. Mechanism of enteric loss of plasma-protein and fat.","volume":"1","author":"Mistilis","year":"1965","journal-title":"Lancet"},{"key":"2021121023274433900_B15","first-page":"732","article-title":"Gastrointestinal diseases: malabsorption","volume-title":"Cecil Textbook of Medicine","author":"Toskes","year":"1988","edition":"18th ed."},{"issue":"976","key":"2021121023274433900_B16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1259\/bjr\/64849421","article-title":"The effectiveness of lymphangiography as a treatment method for various chyle leakages.","volume":"82","author":"Matsumoto","year":"2009","journal-title":"Br J Radiol"},{"issue":"8","key":"2021121023274433900_B17","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2165\/00003495-200464080-00005","article-title":"Everolimus.","volume":"64","author":"Chapman","year":"2004","journal-title":"Drugs"},{"issue":"1","key":"2021121023274433900_B18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2005.10.005","article-title":"Everolimus (Certican) in renal transplantation: A review of clinical trial data, current usage and future directions.","volume":"20","author":"Pascual","year":"2006","journal-title":"Transplant Rev"},{"issue":"4","key":"2021121023274433900_B19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1399-0012.2007.00686.x","article-title":"Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.","volume":"21","author":"Tenderich","year":"2007","journal-title":"Clin Transplant"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2562\/930552\/peds_20152562.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2015-2562\/930552\/peds_20152562.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T08:01:19Z","timestamp":1639209679000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/137\/3\/e20152562\/81403\/Everolimus-for-Primary-Intestinal-Lymphangiectasia"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,1]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2016,3,1]]},"published-print":{"date-parts":[[2016,3,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2015-2562","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,1]]},"article-number":"e20152562"}}